S3F0 fundamentals
SANTHERA PHARMACEUTICALS HOLDING LTD. financial statements, including revenue, expenses, and profit
The total revenue of S3F0 for the last semiannual is 26.59 M EUR, and it's 81.44% higher compared to the previous semiannual. The net income of H2 24 is -28.41 M EUR.
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
TTM